Federal
COVID–19 Emergency Medical Supplies Enhancement Act of 2021
Source: Congress.gov ·
2,518 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
IIB
117TH CONGRESS
1ST SESSION H. R. 3125
IN THE SENATE OF THE UNITED STATES
MAY 19, 2021
Received; read twice and referred to the Committee on Banking, Housing, and
Urban Affairs
AN ACT
To enhance authorities under the Defense Production Act
of 1950 to respond to the COVID–19 emergency, to
provide additional oversight of such authorities, and for
other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3125.RFS
H3125
kjohnson on DSK79L0C42PROD with BILLS
2
HR 3125 RFS
SECTION 1. SHORT TITLE.
1
This Act may be cited as the ‘‘COVID–19 Emergency
2
Medical Supplies Enhancement Act of 2021’’.
3
SEC. 2. DETERMINATION ON EMERGENCY SUPPLIES AND
4
OTHER PUBLIC HEALTH EMERGENCIES.
5
(a) COVID–19 PANDEMIC RESPONSE.—For the pur-
6
poses of section 101 of the Defense Production Act of
7
1950 (50 U.S.C. 4511), the following materials may be
8
deemed by the President, during the COVID–19 emer-
9
gency period, to be scarce and critical materials essential
10
to the national defense and otherwise meet the require-
11
ments of section 101(b) of such Act, and funds available
12
to implement such Act may be used for the purchase, pro-
13
duction (including the construction, repair, and retro-
14
fitting of government-owned facilities as necessary), or
15
distribution of such materials:
16
(1) In vitro diagnostic products (as defined in
17
section 809.3(a) of title 21, Code of Federal Regula-
18
tions) for the detection of SARS–CoV–2 or the diag-
19
nosis of the virus that causes COVID–19, and the
20
reagents and other materials necessary for pro-
21
ducing, conducting, or administering such products,
22
and the machinery, equipment, laboratory capacity,
23
or other technology necessary to produce such prod-
24
ucts.
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3125.RFS
H3125
kjohnson on DSK79L0C42PROD with BILLS
3
HR 3125 RFS
(2) Face masks and personal protective equip-
1
ment, including non-surgical isolation gowns, face
2
shields, nitrile gloves, N–95 filtering facepiece res-
3
pirators, and any other masks or equipment (includ-
4
ing durable medical equipment) determined by the
5
Secretary of Health and Human Services to be need-
6
ed to respond to the COVID–19 pandemic, and the
7
materials, machinery, additional manufacturing lines
8
or facilities, or other technology necessary to
9
produce such equipment.
10
(3) Drugs and devices (as those terms are de-
11
fined in the Federal Food, Drug, and Cosmetic Act
12
(21 U.S.C. 301 et seq.)) and biological products (as
13
that term is defined by section 351 of the Public
14
Health Service Act (42 U.S.C. 262)) that are ap-
15
proved, cleared, licensed, or authorized under either
16
of such Acts for use in treating or preventing
17
COVID–19 and symptoms related to COVID–19,
18
and any materials, manufacturing machinery, addi-
19
tional manufacturing or fill-finish lines or facilities,
20
technology, or equipment (including durable medical
21
equipment) necessary to produce or use such drugs,
22
biological products, or devices (including syringes,
23
vials, or other supplies or equipment related to deliv-
24
ery, distribution, or administration).
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3125.RFS
H3125
kjohnson on DSK79L0C42PROD with BILLS
4
HR 3125 RFS
(4) Any other medical equipment or supplies
1
determined by the Secretary of Health and Human
2
Services or the Secretary of Homeland Security to
3
be scarce and critical materials essential to the na-
4
tional defense for purposes of section 101 of the De-
5
fense Production Act of 1950 (50 U.S.C. 4511).
6
(b) FUTURE PREPAREDNESS FOR HEALTH EMER-
7
GENCIES.—Section 702(14) of the Defense Production
8
Act of 1950 is amended by striking ‘‘and critical infra-
9
structure protection and restoration’’ and inserting ‘‘, crit-
10
ical infrastructure protection and restoration, and public
11
health emergency preparedness and response activities’’.
12
SEC. 3. EXERCISE OF TITLE I AUTHORITIES IN RELATION
13
TO CONTRACTS BY STATE, LOCAL, OR TRIBAL
14
GOVERNMENTS.
15
(a) IN GENERAL.—In exercising authorities under
16
title I of the Defense Production Act of 1950 (50 U.S.C.
17
4511 et seq.) during the COVID–19 emergency period, the
18
President (and any officer or employee of the United
19
States to which authorities under such title I have been
20
delegated)—
21
(1) may exercise the prioritization or allocation
22
authority provided in such title I to exclude any ma-
23
terials described in section 2 ordered by a State,
24
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H3125.RFS
H3125
kjohnson on DSK79L0C42PROD with BILLS
5
HR 3125 RFS
local, or Tribal government that are scheduled to be
1
delivered within 15 days of the time at which—
2
(A) the purchase order or contract by the
3
Federal Government for such materials is
4
made; or
5
(B) the materials are otherwise allocated
6
by the Federal Government under the authori-
7
ties contained in such Act; and
8
(2) shall, within 24 hours of any exercise of the
9
prioritization or allocation authority provided in such
10
title I—
11
(A) to the extent practicable notify any
12
State, local, or Tribal government if the Presi-
13
dent determines that the exercise of such au-
14
thorities would delay the receipt of such mate-
15
rials ordered by such government; and
16
(B) take such steps as may be necessary,
17
and as authorized by law, to ensure that such
18
materials ordered by such government are deliv-
19
ered in the shortest possible period, consistent
20
with the purposes of the Defense Production
21
Act of 1950.
22
(b) UPDATE TO FEDERAL REGULATIONS.—
23
(1) DPAS.—Not later than 30 days after the
24
date of enactment of this Act, the Defense Property
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H3125.RFS
H3125
kjohnson on DSK79L0C42PROD with BILLS
6
HR 3125 RFS
Accountability System regulations (15 C.F.R. part
1
700) shall be revised to reflect the requirements of
2
subsection (a).
3
(2) FAR.—Not later than 30 days after the re-
4
visions required by paragraph (1) are made, the
5
Federal Acquisition Regulation shall be revised to
6
reflect the requirements of subsection (a), consistent
7
with the revisions made pursuant to paragraph (1).
8
SEC. 4. ENGAGEMENT WITH THE PRIVATE SECTOR.
9
(a) OUTREACH REPRESENTATIVE.—Consistent with
10
the authorities in title VII of the Defense Production Act
11
of 1950 (50 U.S.C. 4551 et seq.), the Administrator of
12
the Federal Emergency Management Agency, in consulta-
13
tion with the Secretary of Health and Human Services,
14
may designate or appoint, pursuant to section 703 of such
15
Act (50 U.S.C. 4553), an individual to be known as the
16
‘‘Outreach Representative’’ for the COVID–19 emergency
17
period. Such individual shall—
18
(1) be appointed from among individuals with
19
substantial experience in the production or distribu-
20
tion of medical supplies or equipment; and
21
(2) act as the Government-wide single point of
22
contact during the COVID–19 emergency for out-
23
reach to manufacturing companies and their sup-
24
pliers who may be interested in producing medical
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H3125.RFS
H3125
kjohnson on DSK79L0C42PROD with BILLS
7
HR 3125 RFS
supplies or equipment, including the materials de-
1
scribed under section 2.
2
(b) ENCOURAGING
PARTNERSHIPS.—During the
3
COVID–19 emergency period, the Outreach Representa-
4
tive shall seek to develop partnerships between companies,
5
in coordination with any overall coordinator appointed by
6
the President to oversee the response to the COVID–19
7
emergency, including through the exercise of the authori-
8
ties delegated by the President under section 708 of the
9
Defense Production Act of 1950 (50 U.S.C. 4558).
10
SEC. 5. ENHANCEMENT OF SUPPLY CHAIN PRODUCTION.
11
In exercising authority under title III of the Defense
12
Production Act of 1950 (50 U.S.C. 4531 et seq.) with re-
13
spect to materials described in section 2, the President
14
shall seek to ensure that support is provided to companies
15
that comprise the supply chains for reagents, components,
16
raw materials, and other materials and items necessary
17
to produce or use the materials described in section 2 to
18
the extent necessary for the national defense during the
19
COVID–19 emergency period.
20
SEC. 6. ENHANCED REPORTING DURING COVID–19 EMER-
21
GENCY.
22
(a) REPORT ON EXERCISING AUTHORITIES UNDER
23
THE DEFENSE PRODUCTION ACT OF 1950.—
24
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H3125.RFS
H3125
kjohnson on DSK79L0C42PROD with BILLS
8
HR 3125 RFS
(1) IN GENERAL.—Not later than 90 days after
1
the date of the enactment of this Act, the President,
2
in consultation with the Administrator of the Fed-
3
eral Emergency Management Agency, the Secretary
4
of Defense, and the Secretary of Health and Human
5
Services, shall submit to the appropriate congres-
6
sional committees a report on the exercise of au-
7
thorities under titles I, III, and VII of the Defense
8
Production Act of 1950 (50 U.S.C. 4501 et seq.)
9
prior to the date of such report for the purposes of
10
the COVID–19 response.
11
(2) CONTENTS.—The report required under
12
subsection (a) and the update required under para-
13
graph (3) shall include the following:
14
(A) IN GENERAL.—With respect to each
15
exercise of such authority—
16
(i) an explanation of the purpose of
17
the applicable contract, purchase order, or
18
other exercise of authority (including an
19
allocation of materials, services, and facili-
20
ties under section 101(a)(2) of the Defense
21
Production Act of 1950 (50 U.S.C.
22
4511(a)(2));
23
(ii) the cost of such exercise of au-
24
thority; and
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H3125.RFS
H3125
kjohnson on DSK79L0C42PROD with BILLS
9
HR 3125 RFS
(iii) if applicable—
1
(I) the amount of goods that
2
were purchased or allocated;
3
(II) an identification of the entity
4
awarded a contract or purchase order
5
or that was the subject of the exercise
6
of authority; and
7
(III) an identification of any en-
8
tity that had shipments delayed by the
9
exercise of any authority under the
10
Defense Production Act of 1950 (50
11
U.S.C. 4501 et seq.).
12
(B) CONSULTATIONS.—A description of
13
any consultations conducted with relevant
14
stakeholders on the needs addressed by the ex-
15
ercise of the authorities described in paragraph
16
(1).
17
(3) UPDATE.—The President shall provide an
18
additional briefing to the appropriate congressional
19
committees on the matters described under para-
20
graph (2) no later than four months after the sub-
21
mission of the report.
22
(b) EXERCISE OF LOAN AUTHORITIES.—
23
(1) IN GENERAL.—Any loan made pursuant to
24
section 302 or 303 of the Defense Production Act of
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H3125.RFS
H3125
kjohnson on DSK79L0C42PROD with BILLS
10
HR 3125 RFS
1950, carried out by the United States International
1
Development Finance Corporation pursuant to the
2
authorities delegated by Executive Order No. 13922,
3
shall be subject to the notification requirements con-
4
tained in section 1446 of the BUILD Act of 2018
5
(22 U.S.C. 9656).
6
(2) APPROPRIATE
CONGRESSIONAL
COMMIT-
7
TEES.—For purposes of the notifications required by
8
paragraph (1) the term ‘‘appropriate congressional
9
committees’’, as used section 1446 of the BUILD
10
Act of 2018, shall be deemed to include the Com-
11
mittee on Financial Services of the House of Rep-
12
resentatives and the Committee on Banking, Hous-
13
ing and Urban Development of the Senate.
14
(c) SUNSET.—The requirements of this section shall
15
terminate on the later of—
16
(1) December 31, 2021; or
17
(2) the end of the COVID–19 emergency pe-
18
riod.
19
SEC. 7. REPORT ON ACTIVITIES INVOLVING SMALL BUSI-
20
NESS.
21
The report required by section 304(f)(3) of the De-
22
fense Production Act of 1950 (50 U.S.C. 4534(f)(3)) for
23
fiscal years 2022 and 2023 shall include the percentage
24
of contracts awarded using funds to carry out the Defense
25
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H3125.RFS
H3125
kjohnson on DSK79L0C42PROD with BILLS
11
HR 3125 RFS
Production Act of 1950 for each of the fiscal years 2022
1
and 2023, respectively, to small business concerns (as de-
2
fined under section 702 of such Act).
3
SEC. 8. DEFINITIONS.
4
In this Act:
5
(1) APPROPRIATE
CONGRESSIONAL
COMMIT-
6
TEES.—The term ‘‘appropriate congressional com-
7
mittees’’ means the Committees on Appropriations,
8
Armed Services, Energy and Commerce, Financial
9
Services, and Homeland Security of the House of
10
Representatives and the Committees on Appropria-
11
tions, Armed Services, Banking, Housing, and
12
Urban Affairs, Health, Education, Labor, and Pen-
13
sions, Homeland Security and Governmental Affairs,
14
and Veterans’ Affairs of the Senate.
15
(2) COVID–19
EMERGENCY
PERIOD.—The
16
term ‘‘COVID–19 emergency period’’ means the pe-
17
riod beginning on the date of enactment of this Act
18
and ending on the earlier of—
19
(A) the end of the incident period for the
20
emergency declared on March 13, 2020, by the
21
President under section 501 of the Robert T.
22
Stafford Disaster Relief and Emergency Assist-
23
ance Act (42 U.S.C. 4121 et seq.) relating to
24
VerDate Sep 11 2014
03:15 May 20, 2021
Jkt 019200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H3125.RFS
H3125
kjohnson on DSK79L0C42PROD with BILLS
12
HR 3125 RFS
the Coronavirus Disease 2019 (COVID–19)
1
pandemic; or
2
(B) September 30, 2025.
3
(3) RELEVANT STAKEHOLDER.—The term ‘‘rel-
4
evant stakeholder’’ means—
5
(A) representative private sector entities;
6
(B) representatives of the nonprofit sector;
7
(C) representatives of primary and sec-
8
ondary school systems; and
9
(D) representatives of organizations rep-
10
resenting workers, including health workers,
11
manufacturers, teachers, other public sector
12
employees, and service sector workers.
13
(4) STATE.—The term ‘‘State’’ means each of
14
the several States, the District of Columbia, the
15
Commonwealth of Puerto Rico, and any territory or
16
possession of the United States.
17
Passed the House of Representatives May 18, 2021.
Attest:
CHERYL
[Text truncated for display. Full text available on Congress.gov.]
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.